BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37577145)

  • 1. Group 2 innate lymphoid cells boost CD8
    Wen J; Cheng S; Wang R; Huang Y; Xu L; Ma L; Ling Z; Xu J; Zhao D; Zhang Y; Sun B
    Oncoimmunology; 2023; 12(1):2243112. PubMed ID: 37577145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33-ILC2 axis promotes anti-tumor CD8
    Okuyama Y; Okajima A; Sakamoto N; Hashimoto A; Tanabe R; Kawajiri A; Kawabe T; Ishii N
    Biochem Biophys Res Commun; 2022 Dec; 637():9-16. PubMed ID: 36375254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
    Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
    Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8
    Wan J; Wu Y; Huang L; Tian Y; Ji X; Abdelaziz MH; Cai W; Dineshkumar K; Lei Y; Yao S; Sun C; Su Z; Wang S; Xu H
    Cancer Lett; 2021 Apr; 502():34-43. PubMed ID: 33429004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
    Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
    Front Immunol; 2021; 12():664218. PubMed ID: 34867937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4
    Lin L; Chen Z; Dai F; Wei JJ; Tang XY; Sun GB
    Auris Nasus Larynx; 2019 Aug; 46(4):533-541. PubMed ID: 30554982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cθ controls type 2 innate lymphoid cell and T
    Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
    J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.
    Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T
    Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
    Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.
    Drake LY; Iijima K; Kita H
    Allergy; 2014 Oct; 69(10):1300-7. PubMed ID: 24939388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct platelet adhesion potentiates group 2 innate lymphoid cell functions.
    Orimo K; Tamari M; Takeda T; Kubo T; Rückert B; Motomura K; Sugiyama H; Yamada A; Saito K; Arae K; Kuriyama M; Hara M; Soyka MB; Ikutani M; Yamaguchi S; Morimoto N; Nakabayashi K; Hata K; Matsuda A; Akdis CA; Sudo K; Saito H; Nakae S; Tamaoki J; Tagaya E; Matsumoto K; Morita H
    Allergy; 2022 Mar; 77(3):843-855. PubMed ID: 34402091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology.
    Sunaga S; Tsunoda J; Teratani T; Mikami Y; Kanai T
    Front Immunol; 2022; 13():867351. PubMed ID: 35707544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ST2 Nanoparticle Alleviates Lung Inflammation by Targeting ILC2s-CD4
    Wu Y; Shi W; Wang H; Yue J; Mao Y; Zhou W; Kong X; Guo Q; Zhang L; Xu P; Wang Y
    Int J Nanomedicine; 2020; 15():9745-9758. PubMed ID: 33299314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice.
    Li BW; de Bruijn MJ; Tindemans I; Lukkes M; KleinJan A; Hoogsteden HC; Hendriks RW
    Eur J Immunol; 2016 Jun; 46(6):1392-403. PubMed ID: 27062360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal-Activated ILC2s Promote IL-17A Production in Lung γδ T Cells During Sepsis.
    Chen W; Lai D; Li Y; Wang X; Pan Y; Fang X; Fan J; Shu Q
    Front Immunol; 2021; 12():670676. PubMed ID: 33995408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid.
    Morita H; Kubo T; Rückert B; Ravindran A; Soyka MB; Rinaldi AO; Sugita K; Wawrzyniak M; Wawrzyniak P; Motomura K; Tamari M; Orimo K; Okada N; Arae K; Saito K; Altunbulakli C; Castro-Giner F; Tan G; Neumann A; Sudo K; O'Mahony L; Honda K; Nakae S; Saito H; Mjösberg J; Nilsson G; Matsumoto K; Akdis M; Akdis CA
    J Allergy Clin Immunol; 2019 Jun; 143(6):2190-2201.e9. PubMed ID: 30682454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
    Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
    J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma.
    Klein Wolterink RG; Kleinjan A; van Nimwegen M; Bergen I; de Bruijn M; Levani Y; Hendriks RW
    Eur J Immunol; 2012 May; 42(5):1106-16. PubMed ID: 22539286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
    Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
    J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Blocking NLRP3 Inflammasome on Type II Innate Lymphoid Cell Response in Allergic Rhinitis.
    Gong G; Huang P; Yang C; Huang C; Zhang Z; Chen R; Sun T; Yang G
    Iran J Immunol; 2023 Sep; 3(20):287-302. PubMed ID: 37583131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.